Concepedia

Magdalene Cyra

MC

Statistics

Publications

5

Citations

206

H-Index

5

Active since

2017

Affiliations

University Hospital Münster(Current)

University of Gothenburg

Universität Ulm

Sahlgrenska University Hospital

Deutsches Konsortium für Translationale Krebsforschung

Magdalene Cyra is an author at University Hospital Münster specializing in molecular oncology, oncology, and oncogenic signaling pathways.

ORCID

Publications per year

2017–2019

5

Publications

5

FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma

Marcel Trautmann, Jasmin Menzel, Christian Bertling et al. · Clinical Cancer Research · 2017 · 51 citations

, , +17

SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma

Ilka Isfort, Magdalene Cyra, Sandra Elges et al. · Clinical Cancer Research · 2019 · 44 citations

, , +14

Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma

Marcel Trautmann, Magdalene Cyra, Ilka Isfort et al. · Molecular Cancer Therapeutics · 2019 · 40 citations

, , +17

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone

Ilka Isfort, Sandra Elges, Magdalene Cyra et al. · Scientific Reports · 2019 · 38 citations · Full text

, , +17

Requirement for YAP1 signaling in myxoid liposarcoma

Marcel Trautmann, Ya‐Yun Cheng, Patrizia Jensen et al. · EMBO Molecular Medicine · 2019 · 33 citations · Full text

, , +17

1–5 of 5